GlaxoSmithKline PLC (NYSE:GSK)

40.12
Delayed Data
As of Jun 14
 -0.01 / -0.02%
Today’s Change
36.41
Today|||52-Week Range
42.32
+5.00%
Year-to-Date
Glaxo Inks Genome Research Deal With University of California
Jun 14 / Zacks.comZAK - Paid Partner Content
Better Buy: GlaxoSmithKline vs. Merck
Jun 06 / MotleyFool.comFOO - Paid Partner Content
Christopher Browne: Finding Value Away From Home
Jun 12 / GuruFocus NewsGURU - Paid Partner Content
Glaxo's Nucala Gets CHMP Nod for 2 Self-Administered Options
Jun 05 / Zacks.comZAK - Paid Partner Content
6 Guru Stocks With Low Price-Sales Ratios
Jun 11 / GuruFocus NewsGURU - Paid Partner Content
Emergent (EBS) Wins HHS Contract to Supply VIGIV Product
Jun 04 / Zacks.comZAK - Paid Partner Content
Is Gilead Sciences Worth the Wait?
Jun 09 / MotleyFool.comFOO - Paid Partner Content
Matinas BioPharma to Present at the 9th Annual LD Micro Invitational
Jun 03 / GlobeNewswirePNW - Paid Partner Content

Today’s Trading

Previous close40.13
Today’s open39.95
Day’s range39.92 - 40.15
Volume1,836,589
Average volume (3 months)2,498,224
Market cap$100.0B
Data as of 4:02pm ET, 06/14/2019

Growth & Valuation

Earnings growth (last year)+143.10%
Earnings growth (this year)-8.05%
Earnings growth (next 5 years)+3.85%
Revenue growth (last year)+5.72%
P/E ratio20.3
Price/Sales2.31
Price/Book17.78

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.24-0.60%
SNYSanofi-0.21-0.49%
NVONovo Nordisk-0.74-1.43%
LLYEli Lilly and Co-0.08-0.07%
Data as of 4:02pm ET, 06/14/2019

Financials

Next reporting dateJuly 24, 2019
EPS forecast (this quarter)$0.64
Annual revenue (last year)$41.1B
Annual profit (last year)$4.8B
Net profit margin11.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Iain James Mackay
Corporate headquarters
Brentford, Greater London

Forecasts